
Formosa Laboratories Inc
TWSE:4746

Formosa Laboratories Inc
Total Other Income
Formosa Laboratories Inc
Total Other Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Formosa Laboratories Inc
TWSE:4746
|
Total Other Income
NT$921.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
164%
|
CAGR 10-Years
61%
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Total Other Income
NT$24.3m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-12%
|
|
![]() |
ScinoPharm Taiwan Ltd
TWSE:1789
|
Total Other Income
NT$2.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Total Other Income
NT$441.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
101%
|
CAGR 10-Years
63%
|
|
![]() |
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Total Other Income
NT$61.3m
|
CAGR 3-Years
57%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
![]() |
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Total Other Income
NT$42.7m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-2%
|
Formosa Laboratories Inc
Glance View
Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.

See Also
What is Formosa Laboratories Inc's Total Other Income?
Total Other Income
921.8m
TWD
Based on the financial report for Sep 30, 2024, Formosa Laboratories Inc's Total Other Income amounts to 921.8m TWD.
What is Formosa Laboratories Inc's Total Other Income growth rate?
Total Other Income CAGR 10Y
61%